This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Apple, Oracle, Goldman Sachs and Precipio
by Zacks Equity Research
AAPL, ORCL, GS and PRPO are navigating growth, innovation and risk. See what Zacks analysts say about these standout names.
Top Research Reports for Apple, Oracle & Goldman Sachs
by Mark Vickery
AAPL, ORCL, and GS stand out with cloud strength, AI-driven growth, and investment banking momentum despite macro headwinds.
The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio
by Zacks Equity Research
Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio are part of the Zacks top Analyst Blog
Top Research Reports for Visa, ServiceNow & Progressive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ServiceNow, Inc. (NOW) and The Progressive Corporation (PGR), as well as two micro-cap stocks The Monarch Cement Company (MCEM) and Precipio, Inc. (PRPO).
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio
by Zacks Equity Research
Visa, AbbVie, Analog Devices and Precipio are included in this Analyst Blog.
Top Research Reports for Visa, AbbVie & Analog Devices
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI), as well as a micro-cap stock Precipio, Inc. (PRPO).
Two Smaller Companies Worthy of Your "Attention"
by Mark Zinski
Here we highlight a small cap and a microcap with Zacks Outperform ratings.
Zacks Initiates Coverage of Precipio With Outperform Recommendation
by Debanjana Dey
Discover why Zacks rates Precipio as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore PRPO's approaching breakeven milestones, financial health, and market positioning in the cancer diagnostics space.
Company News for July 06, 2017
by Zacks Equity Research
Companies in the News are: ORLY,BMY,MORE,PRPO